<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Decreased or absent expression of blood group antigens is well known to occur in <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In some <z:mp ids='MP_0002038'>carcinomas</z:mp>, the <z:e sem="disease" ids="C1698088" disease_type="Neoplastic Process" abbrv="">malignant solid tumor</z:e> cells have also been shown to lose <z:mpath ids='MPATH_458'>normal</z:mpath> blood group antigen expression </plain></SENT>
<SENT sid="2" pm="."><plain>In both <z:mp ids='MP_0002038'>carcinoma</z:mp> and <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e>, these findings have been associated with a more <z:hpo ids='HP_0000718'>aggressive behavior</z:hpo> of the <z:hpo ids='HP_0002664'>neoplasm</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>A 34-year-old, group AB, Rh positive woman was diagnosed with a preleukemic condition, <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, in December 1988 </plain></SENT>
<SENT sid="4" pm="."><plain>In April 1989 B antigen expression was markedly decreased, then absent; in November 1989 the patient had progressed to <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>In April 1990 neither A nor B antigens could be detected, there was disease progression, and the patient died 19 days after A and B antigens were undetectable </plain></SENT>
<SENT sid="6" pm="."><plain>Decreased expression of <z:mpath ids='MPATH_458'>normal</z:mpath> blood group antigens may prove useful in differentiating benign from malignant conditions and may indicate a more grave prognosis </plain></SENT>
</text></document>